annual accounts payable:
$12.95M-$2.17M(-14.37%)Summary
- As of today (September 17, 2025), FOLD annual accounts payable is $12.95 million, with the most recent change of -$2.17 million (-14.37%) on December 31, 2024.
- During the last 3 years, FOLD annual accounts payable has fallen by -$8.57 million (-39.82%).
- FOLD annual accounts payable is now -40.40% below its all-time high of $21.72 million, reached on December 31, 2019.
Performance
FOLD Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$13.89M-$558.00K(-3.86%)Summary
- As of today (September 17, 2025), FOLD quarterly accounts payable is $13.89 million, with the most recent change of -$558.00 thousand (-3.86%) on June 30, 2025.
- Over the past year, FOLD quarterly accounts payable has dropped by -$18.16 million (-56.66%).
- FOLD quarterly accounts payable is now -88.46% below its all-time high of $120.37 million, reached on December 31, 2019.
Performance
FOLD quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
FOLD Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.4% | -56.7% |
3 y3 years | -39.8% | -39.9% |
5 y5 years | -40.4% | -2.9% |
FOLD Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -39.8% | at low | -56.7% | +50.9% |
5 y | 5-year | -40.4% | at low | -56.7% | +50.9% |
alltime | all time | -40.4% | +2342.8% | -88.5% | >+9999.0% |
FOLD Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $13.89M(-3.9%) |
Mar 2025 | - | $14.45M(+11.6%) |
Dec 2024 | $12.95M(-14.4%) | $12.95M(-4.0%) |
Sep 2024 | - | $13.48M(-57.9%) |
Jun 2024 | - | $32.06M(+248.1%) |
Mar 2024 | - | $9.21M(-39.1%) |
Dec 2023 | $15.12M(-1.9%) | $15.12M(-34.7%) |
Sep 2023 | - | $23.15M(+71.2%) |
Jun 2023 | - | $13.52M(-45.8%) |
Mar 2023 | - | $24.96M(+62.0%) |
Dec 2022 | $15.41M(-28.4%) | $15.41M(+28.0%) |
Sep 2022 | - | $12.05M(-47.9%) |
Jun 2022 | - | $23.11M(+0.9%) |
Mar 2022 | - | $22.91M(+6.5%) |
Dec 2021 | $21.51M(+26.1%) | $21.51M(-12.1%) |
Sep 2021 | - | $24.47M(+77.8%) |
Jun 2021 | - | $13.76M(-14.6%) |
Mar 2021 | - | $16.11M(-5.6%) |
Dec 2020 | $17.06M(-21.4%) | $17.06M(+15.6%) |
Sep 2020 | - | $14.76M(+3.2%) |
Jun 2020 | - | $14.31M(-11.9%) |
Mar 2020 | - | $16.24M(-86.5%) |
Dec 2019 | $21.72M(+228.8%) | $120.37M(+47.7%) |
Sep 2019 | - | $81.47M(-3.1%) |
Jun 2019 | - | $84.12M(+38.8%) |
Mar 2019 | - | $60.60M(-24.8%) |
Dec 2018 | $6.61M(-16.0%) | $80.63M(+48.4%) |
Sep 2018 | - | $54.33M(+30.6%) |
Jun 2018 | - | $41.61M(-4.7%) |
Mar 2018 | - | $43.68M(+455.2%) |
Dec 2017 | $7.87M(-39.0%) | $7.87M(>+9900.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00(-100.0%) |
Dec 2016 | $12.90M(-21.7%) | $12.90M(-55.5%) |
Sep 2016 | - | $29.01M(+21.8%) |
Jun 2016 | - | $23.83M(>+9900.0%) |
Mar 2016 | - | $0.00(-100.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $16.48M(+180.5%) | $32.22M(+5.4%) |
Sep 2015 | - | $30.57M(+80.8%) |
Jun 2015 | - | $16.90M(+6.7%) |
Mar 2015 | - | $15.83M(-3.1%) |
Dec 2014 | $5.87M(+173.7%) | $16.34M(+44.3%) |
Sep 2014 | - | $11.33M(+14.2%) |
Jun 2014 | - | $9.92M(+8.2%) |
Mar 2014 | - | $9.17M(-9.8%) |
Dec 2013 | $2.15M(+1.5%) | $10.16M(+24.4%) |
Sep 2013 | - | $8.17M(-9.4%) |
Jun 2013 | - | $9.02M(+40.3%) |
Mar 2013 | - | $6.43M(-27.3%) |
Dec 2012 | $2.12M(-17.9%) | $8.85M(-6.2%) |
Sep 2012 | - | $9.43M(+4.0%) |
Jun 2012 | - | $9.07M(+7.3%) |
Mar 2012 | - | $8.45M(-13.0%) |
Dec 2011 | $2.58M(+30.7%) | $9.71M(+19.9%) |
Sep 2011 | - | $8.10M(+15.4%) |
Jun 2011 | - | $7.02M(-5.4%) |
Mar 2011 | - | $7.42M(-10.5%) |
Dec 2010 | $1.97M(-48.6%) | $8.29M(+21.8%) |
Sep 2010 | - | $6.81M(+18.4%) |
Jun 2010 | - | $5.75M(-21.8%) |
Mar 2010 | - | $7.36M(-23.6%) |
Dec 2009 | $3.84M(+93.1%) | $9.63M(-24.5%) |
Sep 2009 | - | $12.76M(+16.1%) |
Jun 2009 | - | $10.99M(+26.5%) |
Mar 2009 | - | $8.68M(+337.0%) |
Dec 2008 | $1.99M(+274.9%) | $1.99M(-79.7%) |
Sep 2008 | - | $9.80M(-8.8%) |
Jun 2008 | - | $10.74M(+923.3%) |
Mar 2008 | - | $1.05M(+98.1%) |
Dec 2007 | $530.00K(-55.7%) | $530.00K(-0.9%) |
Sep 2007 | - | $535.00K(+58.3%) |
Jun 2007 | - | $338.00K(-80.5%) |
Mar 2007 | - | $1.74M(+45.4%) |
Dec 2006 | $1.20M(+31.9%) | $1.20M(+31.9%) |
Dec 2005 | $906.20K(+53.6%) | $906.20K |
Dec 2004 | $589.90K | - |
FAQ
- What is Amicus Therapeutics, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. annual accounts payable year-on-year change?
- What is Amicus Therapeutics, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. quarterly accounts payable year-on-year change?
What is Amicus Therapeutics, Inc. annual accounts payable?
The current annual accounts payable of FOLD is $12.95M
What is the all time high annual accounts payable for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high annual accounts payable is $21.72M
What is Amicus Therapeutics, Inc. annual accounts payable year-on-year change?
Over the past year, FOLD annual accounts payable has changed by -$2.17M (-14.37%)
What is Amicus Therapeutics, Inc. quarterly accounts payable?
The current quarterly accounts payable of FOLD is $13.89M
What is the all time high quarterly accounts payable for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high quarterly accounts payable is $120.37M
What is Amicus Therapeutics, Inc. quarterly accounts payable year-on-year change?
Over the past year, FOLD quarterly accounts payable has changed by -$18.16M (-56.66%)